Over the latest trailing 12-month period, total return cagr is -24.38%. The comparable SPY value is +16.94%. Year-to-date total return is -5.23%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Total Return CAGR averages -79.20% over 3 years and -78.37% over 5 years; the trailing 12 months came in at -24.38%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
Bionano Genomics, Inc. (BNGO)
Total Return growth vs the same calendar quarter one year earlier, last 24 comparable quarters.
Quarter-end value of $100 invested at the start of the available history, with dividends reinvested; the newest quarter may be quarter-to-date. Q4 2026 (2026-10-05): $0.04.
| Year | Total return for the year |
|---|---|
| 2026 (YTD) | -5.23% |
| 2025 | -91.16% |
| 2024 | -84.74% |
| 2023 | -87.05% |
| 2022 | -51.17% |
| 2021 | -2.92% |
| 2020 | +148.39% |
| 2019 | -76.34% |
| Period | Period End | QoQ Return | YoY Return |
|---|---|---|---|
| Q4 2026 (QTD) | 2026-10-05 | N/A | N/A |
| Q3 2026 | 2026-09-30 | N/A | N/A |
| Q2 2026 | 2026-06-26 | N/A | N/A |
| Q1 2026 | 2026-03-31 | N/A | N/A |
| Q4 2025 | 2025-12-29 | N/A | N/A |
| Q3 2025 | 2025-09-29 | N/A | N/A |
| Q2 2025 | 2025-06-30 | N/A | -91.6% |
| Q1 2025 | 2025-03-28 | N/A | -95.4% |
| Q4 2024 | 2024-12-30 | N/A | -86.1% |
| Q3 2024 | 2024-09-30 | -30.5% | -84.4% |
| Q2 2024 | 2024-06-26 | -37.2% | -89.3% |
| Q1 2024 | 2024-03-26 | -49.5% | -90.2% |
| Q4 2023 | 2023-12-28 | -29.0% | -85.9% |
| Q3 2023 | 2023-09-28 | -52.7% | -84.2% |
| Q2 2023 | 2023-06-29 | -42.2% | -56.9% |
| Q1 2023 | 2023-03-29 | -27.4% | -58.9% |
Calendar returns: QoQ compares the prior calendar quarter; YoY compares the same calendar quarter a year earlier. The newest quarter is in progress (quarter-to-date).
